The adherence interview: Better information, better alliance

Psychiatric Annals

Volumn 41, Issue 5, 2011, Pages 279-285

  Weiden, Peter J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960811638     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20110425-07     Document Type: Review

References (26)

1. Weiden PJ, Rao N. Teaching medication compliance to psychiatric residents: placing an orphan topic into a training curriculum. Acad Psychiatry. 2005;29(2):203-210.
2. Weiden P, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21(3):419-428.
3. Weiden PJ, Rapkin B, Mott T, Zygmunt A, Goldman D, Frances A. Rating of medication infl uences (ROMI) scale in schizophrenia. Schizophr Bull. 1994;20(2):297-310.
4. Weiden, P, Burkholder, P, Schooler, N, Weedon, J, Uzenoff, S, Turkington, D. Improving antipsychotic adherence in schizophrenia: A randomized pilot study of a brief CBT-based intervention. Paper presented at: American College of Neuropsychopharmacology. 2006; Boca Raton, FL.
5. Weiden. PJ, Schooler. NR, Weedon. JC, Elmouchtari. A, Sunakawa. A, Goldfinger. SM. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. J Clin Psychiatry. 2009;70(10):1397-1406.
6. Velligan DI, Weiden PJ, Sajatovic M, et al. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. J Psychiatr Pract. 2010;16(1):34-45.
7. Velligan DI, Weiden PJ, Sajatovic M, et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J Psychiatr Pract. 2010;16(5):306-324.
8. Velligan DI, Weiden PJ, Sajatovic M, et al; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1-46.
9. Riley W, Velligan D, Sajatovic M, et al. Adherence to psychiatric treatments. Curr Med Lit Psychiatry. 2009;20(4):89-96.
10. Eisenthal S, Emery R, Lazare A, Udin H. Adherence and the negotiated approach to patienthood. Arch Gen Psychiatry. 1979;36(4):393-398.
11. McCabe R, Heath C, Burns T, Priebe S. Engagement of patients with psychosis in the consultation: conversation analytic study. BMJ. 2002;325(7373):1148-1151.
12. Priebe S, McCabe R. The therapeutic relationship in psychiatric settings. Acta Psychiatr Scand Suppl. 2006;429:69-72.
13. Day JC, Bentall RP, Roberts C, et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry. 2005;62(7):717-724.
14. Nakonezny PA, Byerly MJ, Rush AJ. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity. Psychiatry Res. 2008;157(1-3):259-263.
15. Velligan DI, Lam YW, Glahn DC, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006;32(4):724-742.
16. Fishbein M, Ajzen I. Belief, Attitude, Intention and Behavior. Reading, MA; 1975.
17. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiatry. 1990;47(3):228-235.
18. Rollnick S, Butler CC, Kinnersley P, Gregory J, Mash B. Motivational interviewing. BMJ. 2010;340:c1900.
19. Schiller L, Bennett A. The Quiet Room: A Journey Out of the Torment of Madness. New York, NY: Warner Books; 1994.
20. Naber D. Subjective experiences of schizophrenic patients treated with antipsychotic medications. Int Clin Psychopharmacol. 1998;13(Suppl 1):41-45.
21. Lenert LA, Ziegler J, Lee T, Sommi R, Mahmoud R. Differences in health values among patients, family members, and providers for outcomes in schizophrenia. Med Care. 2000;38(10):1011-1021.
22. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892-909.
23. Weiden P. Understanding and addressing adherence issues in schizophrenia: From theory to practice. J Clin Psychiatry. 2007;68(Suppl 14):14-19.
24. Staring AB, Van der Gaag M, Koopmans GT, et al. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry. 2010;197:448-455.
25. Rathod S, Kingdon D, Smith P, Turkington D. Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics - data on a previously published randomised controlled trial. Schizophr Res. 2005;74(2-3):211-219.
26. Lencer R, Harris MS, Weiden PJ, Steiglitz RD, Vauth R. When Psychopharmacology is Not enough: Using Cognitive Behavioral Therapy Techniques for Persons with Persistent Psychosis. Cambridge, MA: Hogrefe; 2011.